Brief: Annovis Bio Refines Timeline For Parkinson’S Phase Iii Study Data Announcement
24/01/2024 13:49
Jan 24 (Reuters) - Annovis Bio Inc ANVS.N :
* ANNOVIS BIO REFINES TIMELINE FOR PARKINSON’S PHASE III
STUDY
DATA ANNOUNCEMENT
* ANNOVIS BIO INC: ONGOING ANTICIPATION FOR PHASE III DATA
ANNOUNCEMENT INITIALLY SET FOR END OF JANUARY 2024
* ANNOVIS BIO INC: DELIVERY OF CLEANED DATA IS NOW DELAYED
* ANNOVIS BIO INC: COMPANY REMAINS BLINDED TO DATA, AND
STATISTICAL ANALYSIS IS YET TO BE PERFORMED
Source text for Eikon: ID:nGNX9lR1Z4
Further company coverage: ANVS.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Annovis Bio
See all newsAnnovis Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Annovis Bio Q2 loss widens as R&D costs rise
Annovis Bio Inc expected to post a loss of 45 cents a share - Earnings Preview
Brief: Annovis Announces Pricing Of $15.0 Million Public Offering Of Common Stock And Accompanying Warrants
U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman